|
|||||
|
|
Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen |
|
| Institution: | 1. University of Eastern Finland, School of Pharmacy, PROMIS-Centre, FI-70211 Kuopio, Finland;2. VTT Technical Research Center of Finland, Photon Devices & Measurement Solutions, P.O. Box 1199, FI-70211 Kuopio, Finland;1. Late Stage Process Development, Science, Genzyme-A Sanofi Company, 45 New York Ave., Framingham, MA 01702;2. Department of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, MA 02139 |
| Abstract: | We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time. |
| Keywords: | continuous manufacturing advanced manufacturing model-based control tax incentives regulatory incentives personalized medicine stock-outs stockpiles PAT quality |
| 本文献已被 ScienceDirect 等数据库收录！ | |